From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs.
- DOI
- 10.1002/alz.71165
- Published
- 2026-02-01
- Container
- Alzheimers Dement
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/alz.71165,
title = {From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs.},
author = {Giardina SF and Culver A and Ahmed C and Mirescu C and Oblak AL and Brosch J and Clayton WB and Dage JL and Lamb BT and Richardson TI and Small D and Palkowitz AD.},
year = {2026},
journal = {Alzheimers Dement},
doi = {10.1002/alz.71165},
url = {https://doi.org/10.1002/alz.71165}
}RIS
TY - JOUR TI - From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs. AU - Giardina SF AU - Culver A AU - Ahmed C AU - Mirescu C AU - Oblak AL AU - Brosch J AU - Clayton WB AU - Dage JL AU - Lamb BT AU - Richardson TI AU - Small D AU - Palkowitz AD. PY - 2026 JO - Alzheimers Dement DO - 10.1002/alz.71165 UR - https://doi.org/10.1002/alz.71165 ER -
APA
SF, G., A, C., C, A., C, M., AL, O., J, B., WB, C., JL, D., BT, L., TI, R., D, S., & AD., P. (2026). From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs.. Alzheimers Dement. https://doi.org/10.1002/alz.71165
Source records
- europe-pmc · retrieved 2026-09-26T03:14:49.157Z